MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

dose, page-8

  1. 5,269 Posts.
    lightbulb Created with Sketch. 244
    You have posted the information I was looking for in my files, and it confirms my recollection: the Phase 2a trial edwardsh was referring to was conducted exclusively in a male test population.

    The data from phase 2b indicated the possibility of a different response to higher doses in males and females, with males responding and females failing to do so.

    Thus there is a consistency in the two sets of data that has been overlooked by edwardsh.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.